Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 December 2002 | Volume 137 Issue 12 | Pages 961-964
Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear.
Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons.
Design: Population-based cross-sectional study.
Setting: Northeastern Italy.
Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors.
Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores).
Results: 116 persons (2.4% [95% CI, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [CI, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (CI, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (CI, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003).
Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.
Editors' Notes
Context
Contribution
Implications
The Editors
Author and Article Information
From University of Padova, Padova, Italy.
Grant Support: By a grant from the Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
Requests for Single Reprints: Alfredo Alberti, MD, Department of Clinical and Experimental Medicine, Clinica Medica 5, University of Padova, Via Giustiniani 2, 35100 Padova, Italy; e-mail, alfredo.alberti{at}unipd.it.
Current Author Addresses: Drs. Alberti, Noventa, Benvegnù, Boccato, and Gatta: Department of Clinical and Experimental Medicine, Clinica Medica 5, Via Giustiniani 2, 35128 Padova, Italy.
Author Contributions: Conception and design: A. Alberti.
Analysis and interpretation of the data: A. Alberti, L. Benvegnù.
Drafting of the article: A. Alberti.
Critical revision of the article for important intellectual content: A. Gatta.
Final approval of the article: A. Alberti, F. Noventa, L. Benvegnù, S. Boccato.
Provision of study materials or patients: S. Boccato.
Statistical expertise: F. Noventa.
Obtaining of funding: A. Alberti.
Collection and assembly of data: A. Alberti, F. Noventa. BRIEF COMMUNICATION
Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
J. Vecchiet, K. Falasca, P. Cacciatore, P. Zingariello, M. Dalessandro, M. Marinopiccoli, E. D'Amico, C. Palazzi, C. Petrarca, P. Conti, et al. Association between Plasma Interleukin-18 Levels and Liver Injury in Chronic Hepatitis C Virus Infection and Non-Alcoholic Fatty Liver Disease Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M G Rumi, F De Filippi, C La Vecchia, M F Donato, S Gallus, E Del Ninno, and M Colombo Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients Gut, March 1, 2005; 54(3): 402 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tichelli and G. Socie Considerations for Adult Cancer Survivors Hematology, January 1, 2005; 2005(1): 516 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chou, E. C. Clark, and M. Helfand Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, March 16, 2004; 140(6): 465 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peffault de Latour, V. Levy, T. Asselah, P. Marcellin, C. Scieux, L. Ades, R. Traineau, A. Devergie, P. Ribaud, H. Esperou, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation Blood, March 1, 2004; 103(5): 1618 - 1624. [Abstract] [Full Text] [PDF] |
||||